| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
PANACEA BIOTEC LTD. (BSE: 531349)
531349 Technical Analysis
5
| As on 24th Dec 2024 531349 SHARE Price closed @ 434.55 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 150.98 & Strong Buy for SHORT-TERM with Stoploss of 140.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
531349SHARE Price
| Open | 446.95 | Change | Price | % |
| High | 446.95 | 1 Day | 5.20 | 1.21 |
| Low | 410.00 | 1 Week | 295.55 | 212.63 |
| Close | 434.55 | 1 Month | 295.55 | 212.63 |
| Volume | 8948 | 1 Year | 275.40 | 173.04 |
| 52 Week High 446.95 | 52 Week Low 112.70 | ||||
BSE INDIA Most Active Stocks
| 532822 | 7.47 | -0.13% |
| 532411 | 0.41 | 0.00% |
| 517001 | 0.09 | 12.50% |
| 511700 | 1.01 | -0.98% |
| 512149 | 0.88 | 0.00% |
| 511389 | 7.25 | -2.42% |
| 534690 | 7.65 | 4.79% |
| 532775 | 2.04 | -0.97% |
| 531328 | 1.05 | 0.96% |
| 532648 | 19.80 | -0.60% |
BSE INDIA Top Gainers Stocks
BSE INDIA Top Losers Stocks
| 531349 Daily Charts |
531349 Intraday Charts |
Whats New @ Bazaartrend |
531349 Free Analysis |
|
|
531349 Important Levels Intraday
| RESISTANCE | 505.75 |
| RESISTANCE | 482.92 |
| RESISTANCE | 468.80 |
| RESISTANCE | 454.69 |
| SUPPORT | 414.41 |
| SUPPORT | 400.30 |
| SUPPORT | 386.18 |
| SUPPORT | 363.35 |
531349 Target April 2025
| 4th UP Target | 0 |
| 3rd UP Target | 0 |
| 2nd UP Target | 0 |
| 1st UP Target | 0 |
| 1st DOWN Target | 0 |
| 2nd DOWN Target | 0 |
| 3rd DOWN Target | 0 |
| 4th DOWN Target | 0 |
531349 Weekly Target
| 4th UP Target | 0.00 |
| 3rd UP Target | 0.00 |
| 2nd UP Target | 0.00 |
| 1st UP Target | 0.00 |
| 1st DOWN Target | 0.00 |
| 2nd DOWN Target | 0.00 |
| 3rd DOWN Target | 0.00 |
| 4th DOWN Target | 0.00 |
531349 Target2025
| 4th UP Target | 312.19 |
| 3rd UP Target | 265.96 |
| 2nd UP Target | 237.39 |
| 1st UP Target | 208.82 |
| 1st DOWN Target | 127.28 |
| 2nd DOWN Target | 98.71 |
| 3rd DOWN Target | 70.14 |
| 4th DOWN Target | 23.91 |
PANACEA BIOTEC LTD. ( BSE INDIA Symbol : 531349 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
531349 Business Profile
Panacea Biotec Limited, a biotechnology company, researches and develops, manufactures, markets, and sells pharmaceuticals, vaccines, and biosimilar in India. The company operates through Vaccines, Formulations, and Research and Development segments. Its product portfolio includes prescription products in various therapeutic areas, including pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, and gastro-intestinal care products, as well as vaccines. The company also exports its products to the Commonwealth of Independent States, Africa, the Middle East, and Asia. It has a collaboration agreement with Refana Inc. for the development, manufacturing, and distribution of the Covid-19 vaccine. Panacea Biotec Limited was founded in 1984 and is based in New Delhi, India. Address: B-1 Extension/G-3, New Delhi, India, 110044
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service